All News about Ensysce Biosciences Inc![]() Via ACCESSWIRE
![]() ![]() ![]()
Ensysce Biosciences Completes Scale Up Manufacture of PF614 to Support Phase 3 Studies
September 14, 2023
Via ACCESSWIRE
![]()
Ensysce Presents "A New Generation of Safer Pain Treatments"
September 07, 2023
Via ACCESSWIRE
![]()
Biosciences to Present at the H.C. Wainwright 25th Annual Global Investment Conference
September 05, 2023
Via ACCESSWIRE
![]() ![]() ![]() Via ACCESSWIRE
![]()
Ensysce Biosciences Announces IRB Approval of Key Study Protocol
August 08, 2023
Via ACCESSWIRE
![]() Via ACCESSWIRE
![]() Via Benzinga
![]() Via Benzinga
![]() ![]() Via Benzinga
![]() Via ACCESSWIRE
![]() ![]() ![]() Via Benzinga
![]() ![]() ![]()
Ensysce Biosciences Regains Compliance with Nasdaq
June 13, 2023
Via ACCESSWIRE
![]() ![]() ![]() Via Benzinga
![]() ![]() ![]() Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|